Oregon Health & Science University
Portland, Oregon, 97239, United States
Location contact
MinKyoung Song, PhD, RN
CONTACT
MinKyoung Song, PhD, RN
PRINCIPAL_INVESTIGATOR
CONTACT
NCT Number: NCT07083895
In this study, the investigators will tailor an existing intervention (Rural Caregiver Heart Health Education (RICHH)) protocol and test its feasibility, acceptability, and initial effect with grandparent caregivers.
Trial opening soon.
Get Notified21 year and older
All sexes
Interventional
Not applicable
Portland, Oregon, 97239, United States
MinKyoung Song, PhD, RN
CONTACT
MinKyoung Song, PhD, RN
PRINCIPAL_INVESTIGATOR
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Grandparent (inclusion):
Grandparent (exclusion)
The RICHH intervention is an educational-behavioral and counseling intervention that promotes caregivers' knowledge, skills and motivation to engage in CVD risk reduction. The intervention is delivered individually to caregivers in their homes using video-conferencing technology on mini-iPads. The program consists of 12 weekly sessions [30-45 minutes] that will be held at the caregivers' preferred times. RICHH consists of 6 interactive modules (i.e., self-management for heart health, depressive symptom management, heart healthy eating, physical activity, co-morbid condition management, and adherence to medication and smoking cessation).
The modified RICHH intervention utilizes focus group outcomes to employ modifications needed to target custodial grandparents from varied backgrounds (e.g., high ACEs, SDoH groups).
Referral to primary care provider
Other names: Usual Care
Time frame: 4 months after baseline and 6 months after baseline
Feasibility is measured by the count of participants who complete the intervention and follow-up components of the study
Time frame: 4 months after baseline
Acceptability will be assessed in the domains of affective attitude, burden, opportunity costs, perceived effectiveness, and self-efficacy
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
Measured using ActiGraph GT9X Link devices. The ActiGraph algorithms generate accurate and reliable data on total energy expenditure (kcal/day). Participants will wear the devices over 7-day periods at each data collection point. For each participant, the average proportion of time per day in moderate-to-vigorous physical activity (MVPA), out of total time wearing the monitors, will be calculated.
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
Measured using the self-report Viocare Food Frequency Questionnaire. Data from Viocare will be used to generate Healthy Eating Index scores, which range from 0 to 100. Higher scores indicate better dietary quality.
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
BMI (kg/m2) will be calculated from height and body weight measured
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
Measured by the average of three consecutive resting blood pressure measurements (both systolic and diastolic pressures).
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
Measured using non-fasting total cholesterol obtained via finger stick
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
Measured using non-fasting HbA1c obtained via finger stick
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
Assessed via self-report of cigarette use/inhaled nicotine use, or secondhand smoke exposure. AHA Life's Essential 8 algorithm will generate a score (0-100), with lower scores indicating greater risk.
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9). Scores range from 0 to 27, with higher scores indicating more severe depressive symptoms.
Time frame: At baseline, 4 months after baseline, and 6 months after baseline
Waist circumference will be measured using a nonextensible tape. At least two independent measurements will be taken and averaged.
Contact information is provided by the study sponsor or research team.
Oregon Health and Science University
Other
Acronym: ECG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07067398
Cardiovascular, Cardiovascular (CV) Risk
New York, United States
View Trial DetailsNCT07363980
Anxiety Disorders, Arthritis
Aarhus, Denmark
View Trial DetailsNCT07128771
Cardiovascular Disease (CVD) Risk Factors, Cardiovascular Diseases
Oslo, Norway
View Trial DetailsNCT00517686
Behavior, Cardiovascular Disease (CVD) Risk Factors
Oakland, California, United States
View Trial Details